세계의 군유전체학 시장 : 용도별, 기술별, 제품별, 사용자별 예측을 포함한 분석 - 주요 컨설턴트 가이드 포함(2026-2030년)
Metagenomic Markets. Global Market Analysis with Forecasts by Applications, Technologies, Product and User. With Executive and Consultant Guides. 2026 to 2030
상품코드:1826003
리서치사:Howe Sound Research
발행일:2025년 09월
페이지 정보:영문 374 Pages
라이선스 & 가격 (부가세 별도)
한글목차
보고서 개요
무한한 성장 가능성? 게임 체인저? 과장이 아닙니다. 군유전체학 분석은 치료 방식을 변경할 수 있습니다. 이 새로운 조사 보고서에서 그 모든 것을 배울 수 있습니다.
건강과 질병에서 유전학의 역할은 지금 바로 이해되고 있습니다. 이 새로운 지식은 비용의 감소와 함께 새로운 유형의 유전자 검사에 박차를 가하고 있습니다. 그것은 완전히 새로운 접근법입니다. 만성 감염? 진범인을 찾아내는 마이크로바이옴과 장내 환경의 비밀? 군유전체학은 그 대답을 가지고 있습니다. 인간 치료부터 폐수 연구에 이르기까지 이 새로운 접근법은 놀라운 대답을 만들어 냈습니다. 이미 작은 의학적 기적도 일어나고 있습니다. 이 보고서는 기술, 용도, 사용자 및 판매되는 제품 유형에 대해 논의합니다. 보고서에는 14 개국과 5개 지역에 대한 자세한 내역이 포함되어 있습니다.
전문용어도 알기 쉽게 해설했습니다. 과제는? 기회와 함정을 찾으십시오. 향후 5년간의 성장 예측과 최종 시장 예측을 이해합니다.
Unlimited growth potential? A Game Changer? It is not exaggeration. Metagenomic assays could change the way medical treatment is done. Learn all about it in this new research report.
The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower costs is driving a new type of genetic testing. ItIs a whole new approach. Chronic infection? Find out the real culprits. Secrets of the microbiome and gut health? Metagenomics has the answers. In everything from human medical treatment to wastewater studies this new approach is creating startling answers. Already some minor medical miracles have been accomplished. This report looks at the technology, the applications, the users and the types of products that will be sold. The report includes detailed breakouts for 14 countries and 5 regions.
Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Table of Contents
1. Market Guides
1.1. Strategic Situation Analysis
1.2. Guide for Executives and Business Development Staff
1.3. Guide for Management Consultants and Investment Advisors
2. Introduction and Market Definition
2.1. What is Metagenomics?
2.2. Market Definition
2.2.1. Revenue Market Size.
2.2.2. Clinical
2.2.3. Microbiome
2.2.4. Agricultural
2.2.5. Environmental & Other
2.3. Methodology
2.3.1. Methodology
2.3.2. Sources
2.3.3. Authors
2.4. Perspective: Healthcare Spending
2.4.1. Global Healthcare Spending
2.4.2. Spending on Healthcare and Pharmaceuticals
2.4.3. Spending on Diagnostics
2.4.4. Important Role of Insurance for Medical Services
2.5. Chromosomes, Genes and Epigenetics
2.5.1. Chromosomes
2.5.2. Genes
2.5.3. Epigenetics
3. Market Overview
3.1. Players in a Dynamic Market
3.1.1. Academic Research Lab
3.1.2. Diagnostic Test Developer
3.1.3. Instrumentation Supplier
3.1.4. Chemical/Reagent Supplier
3.1.5. Pathology Supplier
3.1.6. Independent Clinical Laboratory
3.1.7. Public National/regional Laboratory
3.1.8. Hospital Laboratory
3.1.9. Physicians Office Lab (POLS)
3.1.10. Audit Body
3.1.11. Certification Body
3.2. Metagenomics Applications
3.2.1. Clinical Metagenomics
3.2.2. Diagnostic Use
3.2.3. Syndromic Multiplex vs. Metagenomic Testing
3.2.4. Antimicrobial Resistance
3.2.5. Managing the Microbiome
3.2.6. Public Health Use
3.3. Clinical Industry Structure
3.3.1. Hospital's Testing Share
3.3.2. Economies of Scale
3.3.3. Hospital vs. Central Lab
3.3.4. Physician Office Lab's
3.3.5. Physician's and POCT
4. Market Trends
4.1. Factors Driving Growth
4.1.1. A New Approach to Diagnostics
4.1.2. The Aging Effect
4.1.3. The Known and the Unknown
4.1.4. A Research Bonanza
4.2. Factors Limiting Growth
4.2.1. Increased Competition Lowers Price
4.2.2. Lower Costs
4.2.3. Testing usage analysis curtailing growth
4.2.4. Wellness has a downside
4.3. Instrumentation, Automation and Diagnostic Trends
4.3.1. Traditional Automation and Centralization
4.3.2. The New Automation, Decentralization and Point of Care
4.3.3. Instruments Key to Market Share
4.3.4. Bioinformatics Plays a Role
4.3.5. PCR Takes Command
4.3.6. Next Generation Sequencing Fuels a Revolution
4.3.7. NGS Impact on Pricing
4.3.8. Whole Genome Sequencing, A Brave New World
4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
